Sign in

Máté Kiss

@matekiss.bsky.social
91 followers 129 following 8 posts

Group Leader at the Georg-Speyer-Haus Institute in Frankfurt, Germany

PostsRepliesMedia
Reposted by Máté Kiss
Frankfurt Cancer Institute @loewe-fci.bsky.social · 26/03/2026
📢 Abstract deadline extended to April 10! Join the #FrankfurtCancerConference 2026 (Sept 2–4) at @Goethe University Frankfurt. Submit your abstract, present your research & engage with global leaders in #CancerResearch. 🔗 More information and abstract submission: www.frankfurtcancerconference.org
163
Reposted by Máté Kiss
Frankfurt Cancer Institute @loewe-fci.bsky.social · 23/03/2026
⏰ Reminder: Abstracts for the Frankfurt Cancer Conference 2026 are due Mar 26! Share your research and connect with leading cancer researchers. 📅 September 2–4, 2026 📍 @Goethe University Frankfurt (Campus Westend) 🔗 www.frankfurtcancerconference.org #FrankfurtCancerConference
frankfurtcancerconference.org
Cancer Conference 2026 - UCT Frankfurt
The Frankfurt Cancer Conference is a meeting of internationally leading cancer researchers in basic and translational as well as clinical research. It's also an ideal forum for early-career scientists...
143
Reposted by Máté Kiss
Alaz Ozcan @alazozcan.bsky.social · 12/03/2026
Thrilled to welcome the wonderful @adrover.bsky.social to Zurich for our monthly SMyLe @smyle-ch.bsky.social seminar! 📅 March 24 | 16:30 📍 ETH Hönggerberg Join us to hear José present his great science! Special thanks to @syis-ecr.bsky.social for supporting this event!
072
Reposted by Máté Kiss
Frankfurt Cancer Institute @loewe-fci.bsky.social · 09/03/2026
📢 Call for Abstracts - Frankfurt Cancer Conference 2026 Present your research September 2-4 as a poster or get selected for a short talk. Share your work, get feedback, and connect at the international #FrankfurtCancerConference. 📆 Deadline: March 26, 2026 🔗 www.frankfurtcancerconference.org
1116
Reposted by Máté Kiss
Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 03/03/2026
One week left to register for the FEBS Advanced Course on Tumour Microenvironment: From Tumour Heterogeneity to Therapy Resistance. which will be held in May 4-8, 2026, in Crete! 🧑‍🔬 🧪 🔬 There is an excellent line up of internationally recognized speakers! tumourmicroenvironment2026.febsevents.org
tumourmicroenvironment2026.febsevents.org
FEBS Advanced Lecture Course 2026 - Tumour microenvironment: From tumour heterogeneity to therapy resistance
4–8 May 2026 │ Fodele, Greece
012
Máté Kiss @matekiss.bsky.social · 18/02/2026
Our institute is organizing a conference in September with a fantastic list of speakers. Please share with anyone who may be interested!
020
Reposted by Máté Kiss
Alaz Ozcan @alazozcan.bsky.social · 02/02/2026
Really excited for the first SMyLe Seminar Series event of 2026! Looking forward to the opening seminar on Feb 17 at 16:30 with Dr. Máté Kiss. Hope to see many myeloid enthusiasts there and to keep the discussions going over the apero 🍷
011
Máté Kiss @matekiss.bsky.social · 06/01/2026
There is still time to apply for our PhD opening!
000
Reposted by Máté Kiss
Beatrice Zitti @beatricezitti.bsky.social · 19/12/2025
‼️ New study alert ‼️ We are really proud to share that our latest research is finally out 📣 In this work, we explore the spatial and functional regulation of dendritic cells (DCs) within the tumor microenvironment and how these mechanisms impact #cancerprogression and response to #immunotherapy 🧵
172
Máté Kiss @matekiss.bsky.social · 09/12/2025
Applications are now open for a fully-funded PhD position in my group in Frankfurt. Please share with anyone who might be interested! More info: georg-speyer-haus.de/en/karriere/...
georg-speyer-haus.de
Georg-Speyer-Haus: Doctoral Researcher in Cancer Immunology
031
Reposted by Máté Kiss
Johan Duchêne @johanduchene.bsky.social · 29/09/2025
⚠️ Half of commercial antibodies miss their target! So how do you pick the right one for your experiment? Here’s the solution 👉 Antibody characterization data (all tested in KO cells) are now available at: 🔗 onlygoodantibodies.co.uk Tested by @ycharos.bsky.social & @oga-community.bsky.social
onlygoodantibodies.co.uk
OGA - Only Good Antibodies Community
37437
Reposted by Máté Kiss
Adrian Liston @labliston.bsky.social · 19/09/2025
For our #flowcytometry peeps, would you like to have a single fix/perm protocol that is optimised for everything? One that preserves fluorophores while allowing simultaneous TF and cytokine staining? How about 100-fold cheaper? You got it: currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...
currentprotocols.onlinelibrary.wiley.com
1015869
Reposted by Máté Kiss
CalcinottoLab @calcinottolab.bsky.social · 31/07/2025
🚀 Excited to share our latest publication! 👉 www.nature.com/articles/s41... A fantastic collaboration with an incredible team. #BreastCancer #Neutrophils #TumorMicroenvironment #PARPinhibitors #DNARepair #NatureCommunications #CancerImmunology #CalcinottoLab
nature.com
Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition - Nature Communications
Tumor-associated neutrophils exhibit heterogeneity in breast cancer. Here, the authors identify a distinct precursor population (PreNeu) in estrogen receptor-positive tumors. PreNeu suppress homologou...
182
Máté Kiss @matekiss.bsky.social · 30/07/2025
Our new paper is out: Tumors don’t just reprogram monocytes locally. We show in a mouse model that the systemic impact of a tumor can alter the epigenome of peripheral monocytes, repressing IFN-responsive regulatory elements and priming pro-tumor gene programs.
genomemedicine.biomedcentral.com
Epigenomic preconditioning of peripheral monocytes determines their transcriptional response to the tumor microenvironment - Genome Medicine
Background Monocytes are recruited to tumors and undergo transcriptional reprogramming resulting in tumor-promoting functions. Epigenomic features, such as post-translational modification of histones ...
151
Máté Kiss @matekiss.bsky.social · 16/07/2025
Happy to share that I’ll be starting my lab as a junior group leader at the Georg-Speyer-Haus in Frankfurt in 2026. We’ll study how transcriptional regulators control neutrophil function in cancer. I’ll be hiring soon (PhD/lab tech), please reach out if you know someone interested!
0101
Reposted by Máté Kiss
Ángel Álvarez-Prado @alvarezprado.bsky.social · 21/01/2025
🚨We're hiring! We've opened a fully-funded Ph.D. position to join my lab at the #LIH, if you are interested in understanding how genetic variation influences immune responses against cancer, don't hesitate to apply! 🔬 🧪 More info below ⬇️ www.lih.lu/en/job/?valu... #cancer #immunology #genomics
lih.lu
Job » Luxembourg Institute of Health
075